A new perspective on macrophage-targeted drug research: the potential of KDELR2 in bladder cancer immunotherapy
Open Access
- 3 December 2024
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 15, 1485109
Abstract
Introduction: Bladder cancer was recognized as one of the most common malignant tumors in the urinary system, and treatment options remained largely limited to conventional surgery, radiotherapy, and chemotherapy, which limited patient benefits.Methods: Researchers constructed an RNA transcriptome map of bladder cancer by integrating single-cell RNA sequencing and clinical data, identifying potential molecular targets for diagnosis and treatment. We also verified the antitumor activity of the target through in vitro experiment.Results: A distinct tumor cell subpopulation characterized by elevated S100A8 expression exhibited high copy number variation, high stemness, and low differentiation. It interacted with myeloid cells via the MIF-(CD74+CD44) and MIF-(CD74+CXCR4) signaling pathways. This study underscored KDELR2’s role in promoting cell proliferation, invasion, and migration, providing new therapeutic insights. Prognostic analysis revealed that KDELR2 correlated with poor survival, higher immune scores, and increased macrophage infiltration.Discussion: The findings suggested that patients with high KDELR2 expression might benefit from immune checkpoint therapy. KDELR2 was also shown to enhance bladder cancer cell proliferation, invasion, and migration, highlighting it as a promising target for macrophage-focused drug development.Keywords
This publication has 82 references indexed in Scilit:
- Single-cell RNA sequencing explored potential therapeutic targets by revealing the tumor microenvironment of neuroblastoma and its expression in cell deathDiscover Oncology, 2024
- Advances in tumor microenvironment and underlying molecular mechanisms of bladder cancer: a systematic reviewDiscover Oncology, 2024
- Regulatory T cells subgroups in the tumor microenvironment cannot be overlooked: Their involvement in prognosis and treatment strategy in melanomaEnvironmental Toxicology, 2024
- Deciphering the suppressive immune microenvironment of prostate cancer based on CD4+ regulatory T cells: Implications for prognosis and therapy predictionClinical and Translational Medicine, 2024
- Ribosomal protein L32 enhances hepatocellular carcinoma progressionCancer Medicine, 2023
- NUPR1 imparts oncogenic potential in bladder cancerCancer Medicine, 2022
- KDELR2 promotes breast cancer proliferation via HDAC3‐mediated cell cycle progressionCancer Communications, 2021
- Bladder CancerJAMA, 2020
- Regulatory crosstalk within the mammalian unfolded protein responseCellular and Molecular Life Sciences, 2013
- Macrophage plasticity and polarization in tissue repair and remodellingThe Journal of Pathology, 2012